This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.
Zachary Heim, BS
Advertisement
Articles by Zachary Heim, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
2
What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO
3
ACA Enrollment Erosion Deepens After Open Enrollment Ends
4
Efgartigimod Effective in Broad Subsets of Patients With gMG
5